Enter the first few characters of Company and click 'Go'

Wintac Ltd. Company History and Annual Growth Details

YEAR EVENTS
1986 - The Company was originally registered as Recon Pharma, a
partnership firm in year by the following partners namely, Mr. S.
Jayaprakash Mady, Ms. Meenakshi Mady, Ms. Ratnakala Mady and Ms.
Roopa Nagaraj with the main objective of manufacturing and
marketing high quality formulations.

1990 - Recon Pharma Private Limited was incorporated under the Act to
take over the business of the partnership firm Recon Pharma.

1993 - The Company changed its name to Recon Private Limited on 1st
March. The Company subsequently got converted into a Public
Limited Company on 3rd March and received fresh Certificate of
Incorporation on 5th March.

- The Company implemented the backward integration to manufacture
bulk drug viz., Pefloxacin Mesylate mainly for captive
consumption of the Pharma division.

- The Company has received "Quality Excellence Award" for its
formulation facility, for the 1992, from Indian Drug
Manufacturers Association.

- The Company has increased its product range resulting in
substantial increase in business by acquiring certain Trade
Marks.

- The Company has an exclusive Research & Development Centre at
Bangalore.

1994 - Recon's launch of ROLOX was indeed the most talked about
introduction in the Pharmaceutical Industry.

- Recon launched yet another products under the brand name Rhizin.

- Recon has launched a blue green algae, Spirulina under the brand
name RECOLINA.

- The Company entered the Capital Market in December with a public
issue of 10 lakh Equity shares of Rs. 10/- each at a premium of
Rs.90 per share.

1995 - The Company has entered into a strategic alliance with Tech India
Ventures Inc, Lake Forest, Illinois, USA.

- Recon has recently set up a Joint Venture Company in Tanzania,
"Recon (Tanzania) Limited".

- Recon is in the process of setting up a wholly owned subsidiary
at South Africa in order to boost its exports.

- Recon Chemicals Private Limited has become a subsidiary of the
Company with effect from 20th May. Blumen Floriculture (India)
Private Limited, a company carrying on floriculture business, by
virtue of being a subsidiary of Recon Chemicals Pvt. Ltd. has
also become a subsidiary of the Company.

1996 - The Company is proposed to set up projects at Indonesia and Ghana
in collaboration with our counterparts in the respective
countries with Equity participation upto 51% in the Joint Venture
Company.

1997 - Recon Agrotech Limited became the subsidiary of the Company with
effect from 1st August.

- Recon Limited, a Bangalore-based pharmaceutical company, is
setting up a joint venture company in Indonesia.

1998 - Recon has successfully concluded on agreement with National
Biochemicals Corporation, Cleveland, Ohio USA for substantial
quantities of certain drugs.

- Recon is confident of obtaining ISO 9001 certification by
September.

1999 - The Formulation Division saw the successful launch of NOVOSPAR, a
Sparfloxacin formulation, ILIS - a formulation of Lisinopril,
LANS-MD a brand extension of our existing brand LANS-OD.

- The company had also embarked on a collaborative project with
the National Chemicals Laboratory (NCL), Pune, to develop a new
anti-HIV drug.

2000 - The Rs 478-crore Zydus Cadila Healthcare has signed a memorandum
of understanding with Bangalore-based Recon Ltd to acquire its
formulations business for Rs 27 crore.

- The Company have signed a MoU to transfer the trademarks and
know-how related to the formulation business of the company to a
joint venture company to be promoted by Cadila Healthcare Ltd.
and Recon Ltd.

2006

-Mr. Tobby Simon was appointed as Additional Director of the Company.

2011

-Wintac Ltd Issues Rights in the Ratio of 1:3.

2013

-The Registered office of the company has been shifted from old address to 54/1, Boodihal Village, Nelamangala, Bangalore - 562123, Karnataka. Ph: Bd: +91 080-27733370-73, Ph :Bd: +91 08118 329002.

2014
- Wintac Ltd has appointed Mrs. Kavitha Krishnamoorthy as an Additional Director of the Company.

2015
--Wintac issues rights to its existing shareholders in the ratio of 1:1

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article